Monotrim Monotrim 10 Mg/Ml Oral Suspension (Trimethoprim)

Trimethoprim works by selectively inhibiting the bacterial enzyme dihydrofolate reductase. This enzyme is essential for converting dihydrofolic acid to tetrahydrofolic acid, a key step in the synthesis of nucleic acids and proteins. Blocking this pathway hampers bacterial DNA replication and cell division, producing a bacteriostatic effect.

The dose of Monotrim is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, weight, renal function and other clinical factors. No standard dose is provided here; the prescriber will calculate the appropriate regimen for each individual.

Safety data for trimethoprim in pregnancy are limited, and the drug is generally avoided unless the potential benefit outweighs the risk to the fetus. Trimethoprim can be excreted in breast milk, so caution is advised for nursing mothers. Clinicians should evaluate risks and consider alternative therapies when possible.

To order Monotrim, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Monotrim (trimethoprim) is often compared with the combination drug trimethoprim‑sulfamethoxazole (co‑trimoxazole). While both contain trimethoprim, the combination adds a sulfonamide, providing a broader spectrum but also a higher risk of sulfonamide‑related adverse effects. Monotrim may be preferred when a sulfonamide is contraindicated or when a narrower spectrum is desired.

Monotrim should be stored at ambient temperature, preferably below 25 °C. Keep the suspension in its original container, tightly closed, and protect it from moisture, light and extreme temperatures. Do not freeze the product, and discard any suspension that appears discoloured or contains particles.

Monotrim is administered orally as a liquid suspension. The prescribed volume should be measured with a calibrated dosing syringe or cup provided with the product. It can be taken with or without food, unless the prescriber advises otherwise. Patients should follow the exact dosing schedule recommended by their healthcare provider.

Serious risks associated with Monotrim include severe allergic reactions such as anaphylaxis, hematologic disorders like aplastic anemia, agranulocytosis or severe neutropenia, and rare skin conditions such as Stevens‑Johnson syndrome. Kidney injury, particularly interstitial nephritis, may also occur. Patients should seek immediate medical attention if they experience symptoms such as rash, fever, sore throat, bleeding, or difficulty breathing.

Monotrim should not be used by individuals with known hypersensitivity to trimethoprim or any component of the formulation. It is contraindicated in patients with severe renal impairment where dosing cannot be adjusted, and in those with existing folate deficiency unless supplementation is provided. Caution is also advised for patients with a history of blood dyscrasias or severe liver disease.